APA (7th ed.) Citation

TM, S., S, S., J, B., & M, W. (2026). Cost-Minimization Analysis of the Women's Cancer Risk Identification-Quantitative Polymerase Chain Reaction Test for Endometrial Cancer Epigenetic Biomarker Compared With Transvaginal Ultrasound for Triaging Abnormal Uterine Bleeding. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. https://doi.org/10.1016/j.jval.2026.03.2235

Chicago Style (17th ed.) Citation

TM, Snowsill, Sleigh S, Barrett J, and Widschwendter M. "Cost-Minimization Analysis of the Women's Cancer Risk Identification-Quantitative Polymerase Chain Reaction Test for Endometrial Cancer Epigenetic Biomarker Compared With Transvaginal Ultrasound for Triaging Abnormal Uterine Bleeding." Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research 2026. https://doi.org/10.1016/j.jval.2026.03.2235.

MLA (9th ed.) Citation

TM, Snowsill, et al. "Cost-Minimization Analysis of the Women's Cancer Risk Identification-Quantitative Polymerase Chain Reaction Test for Endometrial Cancer Epigenetic Biomarker Compared With Transvaginal Ultrasound for Triaging Abnormal Uterine Bleeding." Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 2026, https://doi.org/10.1016/j.jval.2026.03.2235.